Publication Information

{'id': 'https://openalex.org/W2980911308', 'doi': 'https://doi.org/10.1038/s41375-019-0612-8', 'title': 'How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia', 'display_name': 'How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia', 'publication_year': 2019, 'publication_date': '2019-10-18', 'ids': {'openalex': 'https://openalex.org/W2980911308', 'doi': 'https://doi.org/10.1038/s41375-019-0612-8', 'mag': '2980911308', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/31628431'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/s41375-019-0612-8', 'pdf_url': 'https://www.nature.com/articles/s41375-019-0612-8.pdf', 'source': {'id': 'https://openalex.org/S149476849', 'display_name': 'Leukemia', 'issn_l': '0887-6924', 'issn': ['0887-6924', '1476-5551'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://www.nature.com/articles/s41375-019-0612-8.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5068133376', 'display_name': 'Brian A. Jonas', 'orcid': 'https://orcid.org/0000-0002-4921-5809'}, 'institutions': [{'id': 'https://openalex.org/I84218800', 'display_name': 'University of California, Davis', 'ror': 'https://ror.org/05rrcem69', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I84218800']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Brian A. Jonas', 'raw_affiliation_strings': ['University of California Davis School of Medicine, Division of Hematology and Oncology, Sacramento, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'University of California Davis School of Medicine, Division of Hematology and Oncology, Sacramento, CA, USA', 'institution_ids': ['https://openalex.org/I84218800']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5032549755', 'display_name': 'Daniel A. Pollyea', 'orcid': 'https://orcid.org/0000-0001-6519-4860'}, 'institutions': [{'id': 'https://openalex.org/I921990950', 'display_name': 'University of Colorado Denver', 'ror': 'https://ror.org/02hh7en24', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I921990950']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Daniel A. Pollyea', 'raw_affiliation_strings': ['University of Colorado School of Medicine, Division of Hematology, Aurora, CO, USA'], 'affiliations': [{'raw_affiliation_string': 'University of Colorado School of Medicine, Division of Hematology, Aurora, CO, USA', 'institution_ids': ['https://openalex.org/I921990950']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5068133376', 'https://openalex.org/A5032549755'], 'corresponding_institution_ids': ['https://openalex.org/I84218800', 'https://openalex.org/I921990950'], 'apc_list': {'value': 3890, 'currency': 'EUR', 'value_usd': 4790, 'provenance': 'doaj'}, 'apc_paid': {'value': 3890, 'currency': 'EUR', 'value_usd': 4790, 'provenance': 'doaj'}, 'fwci': 4.705, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 156, 'citation_normalized_percentile': {'value': 0.998348, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '33', 'issue': '12', 'first_page': '2795', 'last_page': '2804'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12172', 'display_name': 'Neutropenia and Cancer Infections', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12919', 'display_name': 'Blood disorders and treatments', 'score': 0.9972, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/venetoclax', 'display_name': 'Venetoclax', 'score': 0.9517144}, {'id': 'https://openalex.org/keywords/hypomethylating-agent', 'display_name': 'Hypomethylating agent', 'score': 0.67217135}, {'id': 'https://openalex.org/keywords/azacitidine', 'display_name': 'Azacitidine', 'score': 0.47556633}, {'id': 'https://openalex.org/keywords/hematology', 'display_name': 'Hematology', 'score': 0.41627818}], 'concepts': [{'id': 'https://openalex.org/C2779675984', 'wikidata': 'https://www.wikidata.org/wiki/Q23671272', 'display_name': 'Venetoclax', 'level': 4, 'score': 0.9517144}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.7448222}, {'id': 'https://openalex.org/C2776012956', 'wikidata': 'https://www.wikidata.org/wiki/Q17125294', 'display_name': 'Hypomethylating agent', 'level': 5, 'score': 0.67217135}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.62894857}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.5035786}, {'id': 'https://openalex.org/C2779282312', 'wikidata': 'https://www.wikidata.org/wiki/Q1956561', 'display_name': 'Myeloid', 'level': 2, 'score': 0.48208526}, {'id': 'https://openalex.org/C2776239401', 'wikidata': 'https://www.wikidata.org/wiki/Q416451', 'display_name': 'Azacitidine', 'level': 5, 'score': 0.47556633}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.46402815}, {'id': 'https://openalex.org/C194409129', 'wikidata': 'https://www.wikidata.org/wiki/Q103824', 'display_name': 'Hematology', 'level': 2, 'score': 0.41627818}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4058764}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.3665645}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.15379125}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.100931585}, {'id': 'https://openalex.org/C190727270', 'wikidata': 'https://www.wikidata.org/wiki/Q874745', 'display_name': 'DNA methylation', 'level': 4, 'score': 0.09114009}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.09020993}, {'id': 'https://openalex.org/C2777938653', 'wikidata': 'https://www.wikidata.org/wiki/Q1088156', 'display_name': 'Chronic lymphocytic leukemia', 'level': 3, 'score': 0.076152205}, {'id': 'https://openalex.org/C150194340', 'wikidata': 'https://www.wikidata.org/wiki/Q26972', 'display_name': 'Gene expression', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019086', 'descriptor_name': 'Bridged Bicyclo Compounds, Heterocyclic', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019175', 'descriptor_name': 'DNA Methylation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D044127', 'descriptor_name': 'Epigenesis, Genetic', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D015470', 'descriptor_name': 'Leukemia, Myeloid, Acute', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D015470', 'descriptor_name': 'Leukemia, Myeloid, Acute', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': True}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019072', 'descriptor_name': 'Antibiotic Prophylaxis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D019086', 'descriptor_name': 'Bridged Bicyclo Compounds, Heterocyclic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019086', 'descriptor_name': 'Bridged Bicyclo Compounds, Heterocyclic', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D019086', 'descriptor_name': 'Bridged Bicyclo Compounds, Heterocyclic', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D019468', 'descriptor_name': 'Disease Management', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D044127', 'descriptor_name': 'Epigenesis, Genetic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015470', 'descriptor_name': 'Leukemia, Myeloid, Acute', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D015470', 'descriptor_name': 'Leukemia, Myeloid, Acute', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D015470', 'descriptor_name': 'Leukemia, Myeloid, Acute', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058990', 'descriptor_name': 'Molecular Targeted Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009181', 'descriptor_name': 'Mycoses', 'qualifier_ui': 'Q000209', 'qualifier_name': 'etiology', 'is_major_topic': False}, {'descriptor_ui': 'D009181', 'descriptor_name': 'Mycoses', 'qualifier_ui': 'Q000628', 'qualifier_name': 'therapy', 'is_major_topic': False}, {'descriptor_ui': 'D009181', 'descriptor_name': 'Mycoses', 'qualifier_ui': 'Q000517', 'qualifier_name': 'prevention & control', 'is_major_topic': False}, {'descriptor_ui': 'D009181', 'descriptor_name': 'Mycoses', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015275', 'descriptor_name': 'Tumor Lysis Syndrome', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D015275', 'descriptor_name': 'Tumor Lysis Syndrome', 'qualifier_ui': 'Q000209', 'qualifier_name': 'etiology', 'is_major_topic': False}, {'descriptor_ui': 'D015275', 'descriptor_name': 'Tumor Lysis Syndrome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/s41375-019-0612-8', 'pdf_url': 'https://www.nature.com/articles/s41375-019-0612-8.pdf', 'source': {'id': 'https://openalex.org/S149476849', 'display_name': 'Leukemia', 'issn_l': '0887-6924', 'issn': ['0887-6924', '1476-5551'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/31628431', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/s41375-019-0612-8', 'pdf_url': 'https://www.nature.com/articles/s41375-019-0612-8.pdf', 'source': {'id': 'https://openalex.org/S149476849', 'display_name': 'Leukemia', 'issn_l': '0887-6924', 'issn': ['0887-6924', '1476-5551'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.45, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 49, 'referenced_works': ['https://openalex.org/W1572539757', 'https://openalex.org/W1600365609', 'https://openalex.org/W1977222836', 'https://openalex.org/W1989345554', 'https://openalex.org/W1991724464', 'https://openalex.org/W2025667794', 'https://openalex.org/W2047122678', 'https://openalex.org/W2066640259', 'https://openalex.org/W2073788073', 'https://openalex.org/W2081391009', 'https://openalex.org/W2089532685', 'https://openalex.org/W2102461774', 'https://openalex.org/W2106084333', 'https://openalex.org/W2110893339', 'https://openalex.org/W2111724321', 'https://openalex.org/W2116061272', 'https://openalex.org/W2117158766', 'https://openalex.org/W2122479144', 'https://openalex.org/W2123859227', 'https://openalex.org/W2124221273', 'https://openalex.org/W2134138207', 'https://openalex.org/W2144395887', 'https://openalex.org/W2192121806', 'https://openalex.org/W2228154648', 'https://openalex.org/W2333325153', 'https://openalex.org/W2339658711', 'https://openalex.org/W2517675534', 'https://openalex.org/W2549790759', 'https://openalex.org/W2583145471', 'https://openalex.org/W2766330759', 'https://openalex.org/W2774533007', 'https://openalex.org/W2781482481', 'https://openalex.org/W2783500974', 'https://openalex.org/W2793886497', 'https://openalex.org/W2800506334', 'https://openalex.org/W2867994608', 'https://openalex.org/W2888763139', 'https://openalex.org/W2890837116', 'https://openalex.org/W2898284215', 'https://openalex.org/W2899472109', 'https://openalex.org/W2903407606', 'https://openalex.org/W2905241592', 'https://openalex.org/W2915860404', 'https://openalex.org/W2922692686', 'https://openalex.org/W2923187498', 'https://openalex.org/W2939577741', 'https://openalex.org/W2952555327', 'https://openalex.org/W2954597010', 'https://openalex.org/W2970178583'], 'related_works': ['https://openalex.org/W4386269915', 'https://openalex.org/W4383340881', 'https://openalex.org/W4362592484', 'https://openalex.org/W4362542584', 'https://openalex.org/W4310159665', 'https://openalex.org/W4301184859', 'https://openalex.org/W4296614602', 'https://openalex.org/W4255364295', 'https://openalex.org/W3131716652', 'https://openalex.org/W2899412336'], 'abstract_inverted_index': {'Abstract': [0], 'Acute': [1], 'myeloid': [2], 'leukemia': [3, 43], '(AML)': [4], 'is': [5, 18, 25, 39, 48, 100, 103], 'associated': [6], 'with': [7, 69], 'poor': [8], 'outcomes,': [9], 'especially': [10], 'in': [11, 14, 30, 41, 67, 85, 164], 'older': [12, 86], 'patients': [13, 87], 'whom': [15], 'the': [16, 31, 42, 57, 119, 123, 136, 158, 165], 'disease': [17], 'most': [19], 'common.': [20], 'B-cell': [21], 'lymphoma': [22], '2': [23], '(BCL-2)': [24], 'an': [26, 49], 'antiapoptotic': [27], 'protein': [28, 52], 'involved': [29], 'survival': [32], 'and': [33, 37, 61, 125, 129, 140, 152, 162], 'maintenance': [34], 'of': [35, 83, 98, 121, 127, 160, 167], 'AML,': [36], 'it': [38, 102], 'overexpressed': [40], 'stem': [44], 'cell': [45], 'population.': [46], 'Venetoclax': [47], 'oral': [50], 'BCL-2': [51], 'inhibitor': [53], 'recently': [54], 'approved': [55], 'by': [56], 'United': [58], 'States': [59], 'Food': [60], 'Drug': [62], 'Administration': [63], '(FDA)': [64], 'for': [65, 80, 91, 157], 'use': [66], 'combination': [68, 159], 'a': [70], 'hypomethylating': [71], 'agent': [72], '(HMA)': [73], '(azacitidine': [74], 'or': [75, 77, 88], 'decitabine)': [76], 'low-dose': [78], 'cytarabine': [79], 'front-line': [81], 'treatment': [82, 166], 'AML': [84], 'those': [89], 'unfit': [90], 'induction': [92], 'chemotherapy.': [93], 'Given': [94], 'that': [95, 106], 'its': [96], 'mechanism': [97], 'action': [99], 'unique,': [101], 'not': [104, 116], 'surprising': [105], 'this': [107], 'widely': [108], 'effective': [109], 'therapy': [110], 'presents': [111], 'unique': [112], 'challenges,': [113], 'including': [114], 'but': [115], 'limited': [117], 'to': [118, 132, 147], 'rapidity': [120], 'responses,': [122], 'rate': [124], 'depth': [126], 'cytopenias,': [128], 'issues': [130], 'related': [131], 'drug–drug': [133], 'interactions.': [134], 'With': [135], 'recent': [137], 'FDA': [138], 'approval': [139], 'increasingly': [141], 'widespread': [142], 'use,': [143], 'we': [144], 'aim': [145], 'here': [146], 'summarize,': [148], 'based': [149], 'on': [150], 'evidence': [151], 'experience,': [153], 'emerging': [154], 'management': [155], 'strategies': [156], 'HMAs': [161], 'venetoclax': [163], 'AML.': [168]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2980911308', 'counts_by_year': [{'year': 2024, 'cited_by_count': 20}, {'year': 2023, 'cited_by_count': 30}, {'year': 2022, 'cited_by_count': 34}, {'year': 2021, 'cited_by_count': 44}, {'year': 2020, 'cited_by_count': 23}, {'year': 2019, 'cited_by_count': 2}], 'updated_date': '2024-12-11T20:21:39.053740', 'created_date': '2019-10-25'}